CRANDELL KEITH sold BOLD
July 1, 2026 · Form 4 insider transaction
CRANDELL KEITH sold 16,000 shares of Boundless Bio, Inc. at $2.49 per share, a transaction worth $39.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
16,000
Price
$2.49
Total value
$39.8K
InsiderCRANDELL KEITH
RoleDirector
CompanyBoundless Bio, Inc. (BOLD)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 1, 2026
Filing dateJuly 6, 2026
Shares owned after0
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a cashless stock option exercise by Kristina Burow. The net proceeds of such exercise were remitted to ARCH Venture Fund IX, L.P. (ARCH IX), ARCH Venture Fund IX Overage, L.P. (ARCH IX Overage), and ARCH Venture Fund X, L.P. (AVF X Overage LP). The stock option was granted to Kristina Burow in connection with her service on the board of directors of the Issuer.